Polypill beats monotherapy for hypertension: results from the QUARTET stud

By Ahmed El-Medany Treatment with a ‘quadpill’ containing quarter doses of four antihypertensive drugs demonstrated better blood pressure control than initial monotherapy with full-dose irbesartan,…

View More Polypill beats monotherapy for hypertension: results from the QUARTET stud

RCP release statement on COVID-19 vaccination for the severely immunosuppressed

On the 13th of September the Royal College of Physicians (RCP) released a statement regarding vaccination in the severely immunocompromised, in response to the Joint…

View More RCP release statement on COVID-19 vaccination for the severely immunosuppressed
Health Inequalities by UK region

Inequalities in Health Alliance calls on Prime Minister to reduce health inequalities.

92 senior representatives of the Inequalities in Health Alliance (IHA) have written to the Prime Minister calling for a cross-government strategy to reduce health inequalities. The letter…

View More Inequalities in Health Alliance calls on Prime Minister to reduce health inequalities.

Highlights from Day 2 of the ESC 2021 congress – APAF-CRT

By Ahmed El-Medany Presented by Professor Michele Brignole, San Luca Hospital, Milan, APAF-CRT was a two-phase trial in individuals with severely symptomatic atrial fibrillation (AF)…

View More Highlights from Day 2 of the ESC 2021 congress – APAF-CRT

Highlights from Day 2 of the ESC 2021 congress – ENVISAGE-TAVI AF

The ENVISAGE-TAVI AF trial demonstrated that Edoxaban’s non-inferiority to warfarin with regards to myocardial infarction (MI), ischaemic stroke, systemic thromboembolism, and valve thrombosis, in participants…

View More Highlights from Day 2 of the ESC 2021 congress – ENVISAGE-TAVI AF